VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 3353 · 116th Congress

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

What it does: CRS summary · Introduced in Senate · Feb 27, 2020

Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

This bill indefinitely extends Medicare coverage of immunosuppressive drugs for kidney transplant recipients for individuals who do not have other coverage. Under current law, Medicare coverage is limited to 36 months following a transplant.

Additionally, the Government Accountability Office must report on the bill's implementation, including any related program integrity issues.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2020

Latest action (Feb 27, 2020): Read twice and referred to the Committee on Finance.

Policy area: Health · Origin: Senate · Introduced: Feb 27, 2020

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.